Results 201 to 210 of about 1,824,501 (365)

Tumor B‐cell infiltration in platinum‐treated advanced muscle‐invasive urothelial carcinoma

Molecular Oncology, EarlyView.
Bladder tumors with higher pretreatment memory B‐cell infiltration were linked to longer survival after cisplatin chemotherapy, but not carboplatin. These tumors also showed more organized immune structures (tertiary lymphoid structures) and a shared pro‐inflammatory B‐cell‐rich community, suggesting that memory B cells may help identify patients most ...
Konrad Stawiski, Júlia Perera‐Bel, Alejo Rodriguez‐Vida, Nuria Juanpere, Jihyun Lee, Daniel E. Michaud, Jennifer L. Guerriero, Kent W. Mouw, Aristotelis Bamias, Filipe L. F. Carvalho, Joaquim Bellmunt   +10 more
wiley   +1 more source

REPROGRAMMING ZFP189 TRANSCRIPTION FACTOR FUNCTION REGULATES DRUG SPECIFIC BEHAVIORAL RESPONSES AND TRANSCRIPTION

IBRO Neuroscience Reports, 2023
Joseph Picone, Peter Hamilton, Xiaohong Cui, Natalie Truby, Kijoon Kim, Gabriella Silva   +5 more
doaj   +1 more source

Loss of proton‐sensing TDAG8 increases tumor progression in mouse models of colon cancer

Molecular Oncology, EarlyView.
Loss of the pH‐sensing receptor TDAG8 accelerates colorectal cancer progression in mice. Animals lacking TDAG8 expression had increased tumor growth, DNA damage, and recruitment of tumor‐associated immune cells, including macrophages, neutrophils, and monocytes.
Ermanno Malagola, Yasmine Illi, Anna Bircher, Marijn Wilmink, Rachele F. Malagutti, Solenn Ottié, Cordelia Schuler, Pedro A. Ruiz, Cheryl de Vallière, Klaus Seuwen, Gerhard Rogler, Martin Hausmann   +11 more
wiley   +1 more source

Editorial: Bacterial transcription factors and the cell cycle, volume II

Frontiers in Microbiology, 2023
Morigen, Monika Glinkowska, Jianping Xie, Richa Priyadarshini, Kazutoshi Kasho   +4 more
doaj   +1 more source

A minimal transcription factor network is sufficient to drive paclitaxel biosynthesis. [PDF]

Sci Adv
Pan Q, Ochoa-Villarreal M, Howat S, Amir R, Yan Z, French CE, Loake GJ, Cui B.   +7 more
europepmc   +1 more source

Hypoxia-inducible factor as a transcriptional factor regulating gene expression in cancer cells [PDF]

, 2011
Ewelina Dondajewska, Wiktoria Maria Suchorska   +1 more
openalex   +1 more source

Epigenetic heterogeneity and plasticity in therapy‐induced tumor states through single‐cell multi‐omics

Molecular Oncology, EarlyView.
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim, Hwiyeong Lee, Jin Hong, Daechan Park   +3 more
wiley   +1 more source

Tomato drought-responsive transcription factor TINY1 suppresses embryonic growth. [PDF]

J Exp Bot
Azriel M, Shohat H, Blinderman D, Weiss D, Zait Y.   +4 more
europepmc   +1 more source

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

Molecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington, Divya L. Dayanidhi, Mohammad Zokaasadi, John B. Mantyh, Pelumi D. Olawuni, Gabrielle Rupprecht, Jeremy M. Force, Shannon McCall, Ashwani K. Bahl, David S. Hsu, Jason A. Somarelli   +10 more
wiley   +1 more source

The HIF-2 transcription factor mediates resistance to ferroptosis in pancreatic cancer. [PDF]

Mol Cell
Hubbi ME, Wang CL, Suhail Y, Almasri NL, Xie J, Hollander EE, Kshitiz, Muir A, Stanger BZ, Dang CV.   +9 more
europepmc   +1 more source